Market Overview - The market experienced a pullback after reaching a high, primarily due to the Federal Reserve's decision to maintain the benchmark interest rate between 4.25% and 4.50%, and the lack of strong stimulus signals from recent policy meetings [2][17][20] - Economic data showed weakness, with the manufacturing PMI falling to 49.3%, leading to a decline in market sentiment and a decrease in risk appetite among investors [2][17][20] - The market is expected to enter a consolidation phase with limited downward space, although individual stock differentiation may increase [3][18][19] Sector Performance - The pharmaceutical sector, particularly innovative drugs, showed strength, driven by favorable policy changes and a recovering market environment [9][10] - The renewable energy sector, including solar and wind energy, is anticipated to remain active due to ongoing global efforts to achieve carbon neutrality and supportive government policies [9][10] - The semiconductor sector is projected to grow significantly, with a forecasted increase of over 15% in the global semiconductor market by 2025, driven by rising demand for AI and high-performance computing [12] - The military industry is expected to receive continued policy support, with a stable increase in defense budgets and potential catalysts from geopolitical tensions [14] Investment Strategy - Investors are advised to focus on high-quality sectors and select stocks with solid fundamentals and reasonable valuations, especially during the earnings verification period in August [3][19] - Caution is recommended for stocks that have risen significantly but have uncertain earnings prospects, as they may face substantial pullback pressure [3][19] - For aggressive investors, attention should be given to technology growth stocks that have corrected to attractive levels, while conservative investors should wait for market stabilization [3][19]